Trending
Revolutionary Shows Promise 4
Revolutionary Shows Promise 3
Revolutionary Shows Promise 1
Revolutionary aids Treatment Shows Promise
Revolutionary Cancer Treatment Shows Promise
FDA Expands Approval of Vonvendi for von Willebrand Disease, Including Pediatric Use
Child Depression Fluctuations may trigger Parent Depression not vice versa: JAMA
Indoor Air Quality and Diet Found to Regulate Inflammation in Childhood: Study Finds
How Smoking Fuels Pancreatic Cancer Growth and Worsens Outcomes: Study Finds Out
Follow Us:
November 02, 2025

Get In Touch

Merck, Eisai to shut down late stage trial of liver cancer therapy Pharma News

Merck, Eisai to shut down late stage trial of liver cancer therapy

  • 31 October 2025
  • 1 day ago

USFDA nod to updated indication for Winrevair in adults with Pulmonary Arterial Hypertension Pharma News

USFDA nod to updated indication for Winrevair in adults with Pulmonary Arterial Hypertension

  • 28 October 2025
  • 4 days ago

Merck gets USFDA priority review for 2 applications for Keytruda, Keytruda Qlex in combo with Padcev for bladder cancer Pharma News

Merck gets USFDA priority review for 2 applications for Keytruda, Keytruda Qlex in combo with Padcev for bladder cancer

  • 25 October 2025
  • 1 week ago

Merck receives positive EU CHMP opinion for Enflonsia for RSV in infants Pharma News

Merck receives positive EU CHMP opinion for Enflonsia for RSV in infants

  • 21 September 2025
  • 1 month ago

Merck injectable version of blockbuster cancer therapy Keytruda gets USFDA approval Oncology

Merck injectable version of blockbuster cancer therapy Keytruda gets USFDA approval

  • 20 September 2025
  • 1 month ago

Merck gets USFDA Breakthrough Therapy Designation for Raludotatug deruxtecan for Platinum-Resistant Ovarian Cancer Oncology

Merck gets USFDA Breakthrough Therapy Designation for Raludotatug deruxtecan for Platinum-Resistant Ovarian Cancer

  • 17 September 2025
  • 1 month ago

Merck KGaA Multiple Sclerosis Drug Fails In Late-Stage Trials Neurology

Merck KGaA Multiple Sclerosis Drug Fails In Late-Stage Trials

  • 04 July 2025
  • 3 months ago

Recent News

SR Post VACANCIES At ESIC Model Hospital Noida, Ch...

  • 02 November, 2025

Pathologist's signature on medical reports not mus...

  • 02 November, 2025

UP Eyes Japanese Investment: 125 Pharma Giants Inv...

  • 02 November, 2025

Delhi Govt to recruit 1,593 senior resident doctor...

  • 02 November, 2025

Daily Newsletter

Get all the top stories from Blogs to keep track.